Atlas Trials

A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous Urticaria

Clinical trial NCT05335499 · COMPLETED

Trial details

NCT number
NCT05335499
Sponsor
Taiho Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Spontaneous Urticaria
Start date
2022-06-28
Primary completion
2023-12-22
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.